A DUAL PHASE 1/2 INVESTIGATOR INITIATED STUDY TO DETERMINE THE MAXIMUM TOLERATED DOSE, SAFETY, AND EFFICACY OF RHENIUM NANOLIPOSOMES (RNL) IN RECURRENT GLIOBLASTOMA (CTRC #12-02)
Principal Investigator(s)
Brenner,Andrew
Funded by
NANOTX THERAPEUTICS
Research Start Date
Status
Inactive